Skip to main content

Table 2 Incidence of venous thromboembolism and adverse events among medical inpatients receiving enoxaparin versus UFH prophylaxis

From: Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients

 

Prophylaxis Received [N(%)]

 

Outcome

Enoxaparin (N = 479)

UFH (N = 2,837)

RR (95% CI)

DVT

8 (1.7)

163 (5.8)

0.29 (0.14, 0.59)

PE

0 (0.0)

32 (1.1)

0

VTE (DVT and/or PE)

8 (1.7)

180 (6.3)

0.26 (0.13,0.53)

Adverse Events:

   

   HIT

0 (0.0)

0 (0.0)

--

   Major Bleed

12 (2.5)

72 (2.5)

0.99 (0.54,1.80)

   Death

25 (5.2)

142 (5.0)

1.04 (0.69, 1.58)

  1. DVT = deep-vein thrombosis; PE = pulmonary embolism; VTE = venous thromboembolism; HIT = heparin-induced thrombocytopenia